WARRANT EXERCISE AND OMNIBUS AMENDMENT AGREEMENTWarrant Exercise and Omnibus Amendment Agreement • August 4th, 2020 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 4th, 2020 Company IndustryThis Warrant Exercise and Omnibus Amendment Agreement (this “Agreement”), dated as of August 3, 2020, is by and between Sonnet BioTherapeutics Holdings, Inc. a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).